The Supervisory Board furthermore appointed Jan Christoph Teetz as CFO of GELITA AG from 1 October 2020. Prior to this, Mr. Teetz was CFO at tesa SE, a company of the Beiersdorf Group, for more than 10 years.
Together with the current COO, Mr. Michael Van Elsacker, the new Executive Board will shape the company’s continued expansion. GELITA has achieved above-market growth in the past and this is to be continued in the future. In line with the "GELITA 2030" strategy, it is essential to quickly implement the strategic initiatives that have been elaborated.
The Supervisory Board is firmly of the opinion that these appointments to the Executive Board will ensure the company’s successful development and enable it to master the challenges of the future.
The Supervisory Board would like to take this opportunity to sincerely express its thanks to the soon to be retiring CEO, Dr. Konert, who has led and developed the company extremely successfully over the past 11 years. He also played a major role in shaping the 2030 strategy.
As the global market leader, the GELITA Group produces collagen proteins in 22 plants on all continents. These include in particular gelatines for the production of food, pharmaceutical products and technical applications as well as collagen peptides for the formulation of products to combat joint pain, for weight reduction, and for cosmetics. The group headquarters are located in Eberbach, Germany. In 2019, the group of companies with 2,500 employees worldwide achieved a turnover of 749 million, thus consolidating its leading position in the world market. GELITA is an active supporting member of the Rhine-Neckar Metropolitan Region.
Telefon: +49 (6271) 8401
Telefax: +49 (6271) 842701
Global Vice President Marketing & Communication
Telefon: +49 (6271) 84-2190